Oxybutynin recalls
Oxybutynin products have been recalled 4 times, most recently on 15 Nov 2023. The recalling company is usually Zydus Pharmaceuticals (USA). The most common reason is potency & assay.
Total recalls4since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Nov 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why oxybutynin is recalled
Companies
Product types
By year
All oxybutynin recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Oxybutynin Chloride Extended-Release Tablet USP, 10 mg recalledOxybutynin | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
| Drug | CLASS II | Oxybutynin Chloride Extended-Release Tablet USP, 15 mg recalledOxybutynin | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
| Drug | CLASS II | Oxybutynin Chloride Extended-Release Tablet USP, 5 mg recalledOxybutynin | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
| Drug | CLASS II | Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) recalledOxybutynin | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.